Close Menu

SEATTLE (GenomeWeb) – At the American College of Medical Genetics and Genomics annual meeting here this week, representatives from Evanston, Illinois-based NorthShore University HealthSystem and the California-based consumer-centered genomics company Color presented early findings from a hereditary cancer testing pilot study that did not require a specific personal or family history.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

May
26
Sponsored by
Lexogen

The emergence of cell clones that are resistant to targeted therapies poses a significant issue in the treatment of metastatic melanoma.